恒生指数早盘涨1.88% 恒生生物科技指数大涨3.77%

Market Overview - The Hang Seng Index rose by 1.88%, gaining 470 points to close at 25,439 points, while the Hang Seng Tech Index increased by 2.35%. The early trading volume in Hong Kong stocks reached HKD 143.8 billion [1]. Biotechnology Sector - The Hang Seng Biotechnology Index surged by 3.77%, with pharmaceutical stocks collectively rising due to the debut of the "dual directory" for drug applications, promoting a "multi-level + innovative support" strategic transformation. Notable stock performances include: - Zhonghui Biotech-B (02627) up by 24% - Jiuyuan Gene (02566) up by 8.99% - Kintor Pharmaceutical (09939) up by 5.7% - Innovent Biologics (01801) up by 7.27% [1]. Individual Company Performances - Heyu-B (02256) increased by 7.38%, reaching a new high, driven by the exercise fee of Pimiatin boosting performance, with a 59% year-on-year increase in net profit for the first half of the year [2]. - Decent Pharmaceuticals-B (06996) rose over 15% as Claudin18.2 ADC is proposed for inclusion as a breakthrough therapy [3]. - Tencent-related companies reported generally better-than-expected earnings, with Tencent Music-SW (01698) up by 15%, and other companies like Reading Group (00772) and Weimob Group (02013) also seeing significant gains [3]. - Chongqing Machinery and Electric (02722) rose by 8.9%, expecting a 50% year-on-year increase in net profit due to rapid growth in AIDC demand [3]. - China Tobacco Hong Kong (06055) increased by over 7%, maintaining its position in the domestic cigarette export duty-free business, with earnings to be announced next Friday [4]. - Q Technology (01478) surged over 8%, with a 167% year-on-year increase in net profit for the first half of the year, leading to target price upgrades from multiple institutions [5]. - Hon Teng Precision (06088) rose over 9% post-earnings, with a 11% increase in revenue for the first half, although net profit declined by 3% [6]. - Minmetals Resources (01208) increased over 9%, with net profit soaring 15 times in the first half, while the company lowered its cost guidance for its mines [7]. - 361 Degrees (01361) fell over 10% post-earnings, with net profit growth slightly below revenue growth, aligning with expectations [8].